SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011154
Filing Date
2022-06-03
Accepted
2022-06-03 16:06:15
Documents
12
Period of Report
2022-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20220527.htm   iXBRL 8-K 51862
  Complete submission text file 0000950170-22-011154.txt   176334

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20220527_pre.xml EX-101.PRE 11051
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20220527.xsd EX-101.SCH 2456
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20220527_lab.xml EX-101.LAB 17944
6 EXTRACTED XBRL INSTANCE DOCUMENT vir-20220527_htm.xml XML 4704
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 22994362
SIC: 2836 Biological Products, (No Diagnostic Substances)